background

Yurtdışı Makaleler

Yurtdışı Makaleler
  1. Özge A, Mısırlı H, Erenoğlu NY. “Bilateral Spontaneous Thalamic Haemorrhages.” Eur J Neurol, 10, 386-388 (1997)
  2. Özge A, Saraçoğlu M, Gürtekin Y, Erenoğlu NY, Akyatan MN. “The Sensitivity of Sympathetic Skin Responses and Standard Electrophysiological Methods in Diagnosis of Diabetic Neuropathy”, Electromyogr Clin Neurophysiol, 40(1), 37-43 (2000)
  3. Hallıoğlu O, Özge A, Çömelekoğlu Ü, Topaloğlu AK, Düzovalı Ö, Yılgör E. “Evaluation of Cerebral Maturation by Visual and Quantitative Analysis of resting EEG in Children with Primary Nocturnal Enuresis”, J Child Neurol, 16(10), 714-718 (2001)
  4. Atis S, Ozge A, Sevim S. “The Brainstem Auditory Evoked Potential Abnormalities in Severe Chronic Obstructive Pulmonary Disease”, Respirology, 6, 225-229 (2001)
  5. Özge A., Karakelle A., Kaleağası H. “Celiac Disease Associated with Recurrent Stroke: A Coincidence or Cerebral Vasculitis?”, Eur J Neurol.8(4), 373-374 (2001)
  6. Özge A, Atış S, Sevim S. “Subclinical Peripheral Neuropathy Associated with Chronic Obstructive Pulmonary Disease,” Electromyogr Clin Neurophysiol, 41(3), 185-191 (2001)
  7. Özge A, Buğdaycı R, Şaşmaz T, Kaleağasi H, Kurt Ö, Karakelle A, Tezcan H, Siva A. “The Sensitivity and Specificity of the Case Definition Criteria in Diagnosis of Headache: A School-Based Epidemiological Study of 5562 Children In Mersin”. Cephalalgia. 22(10), 791-8 (2002) and Cephalalgia 23, 138-145 (2003). (Same article published twice by the journal)
  8. Özge A, Çömelekoğlu Ü, Tataroglu C, Yalcınkaya D, Akyatan MN. “Subtypes of Carpal Tunnel Syndrome: Median Nerve F Wave Parameters”, Clin Neurol Neurosurg; 104, 322-327 (2002)
  9. Tot Ş, Özge A, Çömelekoğlu Ü, Yazıcı K, Bal N. “Association of Quantitative EEG Findings with Clinical Characteristics in Obsessive-Compulsive Disorder: Evidence of Left Frontotemporal Dysfunction”, Can J Psychiatry 47,538-545 (2002)
  10. Tataroğlu C, Kanık A, Şahin G, Özge A, Yalçınkaya D, İdiman F. “Exteroseptive suppression patterns of masseter and temporalis muscles in central and peripheral headache disorders”. Cephalalgia 22, 444-452 (2002)
  11. Atis S, Çömelekoglu Ü, Coskun B, Özge A, Ersöz G, Talas D. “Electrophysiological and Histopathological Evaluation of Respiratory Tract, Diaphragm and Phrenic Nerve after Dichlorvos Inhalation in Rats”, Inhal Toxicol, 14(2),199-215 (2002)
  12. Öztuna V, Özge A, Eskandari MM, Çolak M, Gölpınar A, Kuyurtar F. “Nerve entrapment in painful heel syndrome”. Foot Ankle Int, 23(3), 208-211 (2002)
  13. Çömelekoğlu Ü, Özge A, Coşkun B. “The mode of action of cypermethrine on peripheral nerves”. Journal of Applied Toxicology, 22(6),445-7 (2002)
  14. Özge A, Kaleağası H, Tataroğlu C, Ünal Ö. “Juvenile Familial Amyotyrophic Atherosclerosis: Two siblings in a single family”. Amyotrophic Lateral Sclerosis and Other Motor Neurone Disorders. 3(3), 163-4 (2002)
  15. Arslan E, Ünal Ş, Bağış S, Özge A, Demirkıran F. “Unilateral brachial plexus injury occuring after reduction mammoplasty”. Aesthetic Plastic Surgery, 26(5), 372-4 (2002)
  16. Toros F, Ozge A, Bozlu M, Cayan S. “Hyperventilation response in the electroencephalogram and psychiatric problems in children with primary monosymptomatic nocturnal enuresis”. Scand J Urol Nephrol, 37(6):471-6 (2003)
  17. Özge A, Bugdayci R, Togrol E, Saracoglu M. “The relation of gastrointestinal symptoms to duration of levodopa treatment and severity of Parkinson’s disease”. The Journal of Applied Research, 3(4), 349-355 (2003)
  18. Özge A, Toros F, Comelekoglu U. “The role of hemispheral asymmetry and regional activity of quantitative EEG in children with stuttering”. Child Psychiatry Hum Dev. 34(4), 269-80 (2004)
  19. Sasmaz T, Bugdaycı R, Özge A, Karakelle A, Kurt, Kaleagasi H. “Are parents aware of their schoolchildren’s headaches?” Eur J Public Health, 14(4), 366-8, (2004)
  20. Milcan A, Ozge A, Sahin G, Saracoglu M, Kuyurtar F. “The role of electrophysiological tests in the early diagnosis of posterior interosseous neuropathy in patients thought to have lateral epicondylitis” Acta Orthop Traumatol Turc. 38(5), 326-9 (2004)
  21. Bugdayci R, Ozge A, Sasmaz T, Kurt AO, Kaleagasi H, Karakelle A, Tezcan H, Siva A. “Prevalence and factors affecting headache in Turkish schoolchildren”.Pediatr Int, 47(3), 316-22 (2005).
  22. Özge C, Atis S, Özge A, Duce MN, Saraçoğlu M, Sarıtas E. “Cough headache: frequency, characteristics and the relationship with the characteristics of cough”. European Journal of Pain, 9(4), 383-8 (2005)
  23. Özge C, Özge A, Yılmaz A, Yalçınkaya D.E, Çalıkoğlu M. “Cranial Optic Nerve Invvements in Patients With Severe COPD”. Respirology, 10, 666-672 (2005).
  24. Naycı A, Atış S, Çömelekoğlu Ü, Özge A, Ögenler O, Coşkun B, Zorludemir S. “Sepsis induced early phrenic nerve neuropathy in rats Sepsis induces early phrenic nerve neuropathy in rats”. Eur Respir J, 26(4), 686-92 (2005).
  25. Eskandari MM, Ozge A, Oztuna V, Colak M, Kanik A. “Effect of Patient Age and Duration of Symptoms on Subjective and Objective Outcomes of Carpal Tunnel Surgery”, Orthopedics, 28(6), 600-2 (2005)
  26. Altunkan AA, Özge A, Altınkan ZÖ, Çömelekoğlu Ü, Atıcı Ş, Bilgin E, Doruk N, Oral U. “An altervative method for determination of anaesthesia depth”. J of Applied Research, 5(3), 492-500 (2005)
  27. Özge C, Özge A, Çömelekoğlu Ü, Ünal Ö. “Quantitative EEG Analysis in Patients With Severe COPD: Some Clues of Chronic Hypoxemic Degeneration”. Journal of Neurological Sciences [Turkish] 23:(1)6, 26-35 (2006).
  28. Özge A, Özge C, Öztürk C, Kaleagasi H, Özcan M, Yalçinkaya DE, Özveren N, Yalçin F. “The relationship between migraine and atopic disorders-the contribution of pulmonary function tests and immunological screening”. Cephalalgia, 26(2), 172-9 (2006)
  29. Mısırlı H, Özge A, Somay G, Erdoğan N, Erkal HN, Erenoğlu NY. “Seizure development after stroke”. Int J Clin Pract. 60(12), 1536-41 (2006)
  30. Özge A, Kaleagasi H, Tasmertek FY. “Autonomic headache with autonomic seizures: a case report”. J Headache Pain 7(5), 347-50 (2006)
  31. Bilgin NG, Ozge A, Mert E, Yalcinkaya DE, Kar H. “Importance of electromyography and the electrophysiological severity scale in forensic reports”. J Forensic Sci. 52(3), 698-701 (2007)
  32. Atis S, Nayci A, Ozge A, Çömelekoğlu Ü, Güneş S, Bağdatoğlu Ö. “N-acetylcysteine protects the rats against phrenic nerve dysfunction in sepsis”. Shock, 25, 30-35 (2006)
  33. Özge A, Özge C, Kaleağası H, Yalın OÖ, Ünal Ö, Özgür ES. “Headache in patients with chronic obstructive pulmonary disease: effects of chronic hypoxaemia”. J Headache Pain; 7(1), 37-43 (2006)
  34. Özge C, Özge A, Unal O. “Cognitive and functional deterioration in patients with severe COPD”. Behav Neurol, 17(2), 121-30 (2006)
  35. Özge A. Is childhood migraine an unmaturated form of adult migraine? A¤r’, 19:1, 2007
  36. Özge A, Bu¤daycı R, Şaşmaz T, Kaleağası H, Kurt Ö, Karakelle A, Siva A. The linear trend of headache prevalence and someheadache features in school children. Agri. 2007; 19(2): 20-25.
  37. Onde ME, Ozge A, Senol MG, Togrol E, Ozdag F, Saracoglu M, Misirli H. “The sensitivity of clinical diagnostic methods in the diagnosis of diabetic neuropathy”. J Int Med Res, 36(1), 63-70. (2008)
  38. Mert E, Ozge A, Tasdelen B, Yilmaz A, Bilgin NG. What clues are available for differential diagnosis of headaches in emergency settings? J Headache Pain. 2008 Apr;9(2):89-97. DOI: 10.1007/s10194-008-0015-0. Epub 2008 Feb 5. PMID: 18250963
  39. Ozturk C, Ozge A, Yalin OO, Yilmaz IA, Delialioglu N, Yildiz C, Tesdelen B, Kudiaki C. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlation with cognitive and functional decline. Behav Neurol. 2007;18(4):207-15.
  40. Ozge A, Ozturk C, Dora B, Inan L, Saip S, Ozturk M, et al. Is there an association between migraine and atopic disorders? The results of multicentre migraine attack study. Journal of Neurological Sciences [Turkish] 25:(3)# 15; 196-207, 2008.
  41. Özge A, İnce B, Somay G, Çakmak SE, Uluduz D, Bulkan M, Taşdelen B, Kaleağası H. The Caregiver Burden and Stroke Prognosis. Journal of Neurological Sciences. 2009:26(2)
  42. Kaleağasi H, Ozge A, Toros F, Kar H. [Migraine type childhood headache aggravated by sexual abuse: case report]. Agri. 2009 Apr;21(2):80-82.
  43. Yener GG; Turkuaz Alzheimer Working (TAC) Group. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer’s disease: a multicenter study in Turkey. Cogn Behav Neurol. 2009 Dec;22(4):264-9. DOI: 10.1097/WNN.0b013e3181c14737
  44. Argin MA, Dinç E, Yilmaz A, Altintas E, Pata C, Özge A. Two Cases of Anterior Ischaemic Optic Neuropathy Associated with Interferon-Alpha Treatment. Ret-Vit 2009;17:149-152
  45. Taşdelen B, Helvacı S, Kaleağası H, Özge A. Artificial Neural Network Analysis for Prediction of Headache Prognosis in Elderly Patients. Turkish Journal of Medical Sciences. 2009 39(1):5-12
  46. Yilmaz A, Kaleagasi H, Dogu O, Kara E, Ozge A. Abnormal MRI in a patient with ‘headache with neurological deficits and CSF lymphocytosis (HaNDL)’. Cephalalgia. 2010 May;30(5):615-9. DOI: 10.1111/j.1468-2982.2009.01950.x. Epub 2010 Feb 22.
  47. Yilmaz IA, Ozge A, Erdal ME, Edgünlü TG, Cakmak SE, Yalin OO. Cytokine polymorphism in patients with migraine: some suggestive clues of migraine and inflammation. Pain Med. 2010 Apr;11(4):492-7. DOI: 10.1111/j.1526-4637.2009.00791.x. Epub 2010 Jan 22.
  48. Ozge A, Sasmaz T, Cakmak SE, Kaleagasi H, Siva A. Epidemiological-based childhood headache natural history study: after an interval of six years. Cephalalgia. 2010 Jun;30(6):703-12. DOI: 10.1177/0333102409351797. Epub 2010 Mar 10.
  49. Alp R, Alp SI, Palanci Y, Sur H, Boru UT, Ozge A, Yapici Z. Use of the International Classification of Headache Disorders, Second Edition, criteria in the diagnosis of primary headache in schoolchildren: epidemiology study from eastern Turkey. Cephalalgia. 2010 Jul;30(7):868-77. DOI: 10.1177/0333102409355837. Epub 2010 Mar 10.
  50. Toros F, Özge A, Kütük MÖ, Kaleağası H, Kanık A, Temel GÖ. The Contribution of Youth Self-Report (YSR) in the Diagnosis of Psychiatric Comorbidity of Juvenile Primary Headache Disorders. Journal of Neurological Sciences [Turkish] 27:(2)# 23; 127-138, 2010.
  51. Çakmak SE, Özge A, Üçbilek E, Sezgin O, Söylemez F, Erdal E, Temel GÖ, Kanık A. The investigation of common clinical and genetic indicators of migraine, episodic tension type headache and irritable bowel syndrome. The Journal of Headache and Pain. 2010;11:S44-S45.
  52. Termine C, Ozge A, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J Headache Pain. 2011 Feb;12(1):25-34. DOI: 10.1007/s10194-010-0256-6. Epub 2010 Dec 18.
  53. Kaleagasi H, Ozgur E, Ozge C, Ozge A. Bronchial hyper-reactivity in migraine without aura: is it a new clue for inflammation? Headache. 2011 Mar;51(3):426-431.
  54. Ozge A, Termine C, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part I: diagnosis. J Headache Pain. 2011 Feb;12(1):13-23.
  55. Tasdelen B, Ozge A, Kaleagasi H, Erdogan S, Mengi T. Determining of migraine prognosis using latent growth mixture models. Chin Med J (Engl). 2011 Apr;124(7):1044-9.
  56. Aytaçoğlu H, Köstekçi İ, Taşdelen B, Öksüz N, Toros F, Özge A. The Effects of Daily Variables on Primary Headache Disorders in High-School Children; A Proposal For A Cut-off Value For Study/Leisure Time Regarding Headache Types. Journal of Neurological Sciences [Turkish] 2011;28:(4)# 29;453-464
  57. Benbir G, Ince B, Kumral E, Ongen Z, Kultursay H, Tokgozoglu L, Oto A, Tuzun H; ARDA Investigators. Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality. Inflammation. 2012 Feb;35(1):65-73. DOI: 10.1007/s10753-010-9290-4.
  58. Ankarali H, Temel Orekici G, Tasdelen B, Ozge A. Boosting tree as a stronger approach in classification: An application of carpal tunnel syndrome. J Turgut Ozal Med Cent 2012;19(4):228-33
  59. Özge A. Functional Disability and Its Management in Alzheimer’s Disease. Turkiye Klinikleri J Neurol-Special Topics. 2012;5(3):70-2
  60. Öztürk M, Polat B, Altunkaynak Y, Mutluay B, Öztürk RB, Özge A, Çakmak D, Bayba S. Headache Characteristics in Addicts During Substance Abuse, Withdrawal and Rehabilitation. Journal of Neurological Sciences [Turkish] 29:(3)# 32; 494-502, 2012.
  61. Öztürk V, Ertaş M, Baykan B, Sirin H, Özge A; Mig-Etol Study Group. Efficacy and safety of 400 and 800 mg etodolac vs. 1,000 mg paracetamol in acute treatment of migraine: a randomised, double-blind, crossover, multicenter, phase III clinical trial. Pain Pract. 2013 Mar;13(3):191-7.
  62. Ozge A, Saşmaz T, Buğdaycı R, Cakmak SE, Kurt AÖ, Kaleağası SH, Siva A. The prevalence of chronic and episodic migraine in children and adolescents. Eur J Neurol. 2013 Jan;20(1):95-101.
  63. Akdal G, Ozge A, Ergör G. The prevalence of vestibular symptoms in migraine or tension-type headache. J Vestib Res. 2013 Jan 1;23(2):101-6. DOI: 10.3233/VES-130477
  64. Kiral K, Ozge A, Sungur MA, Tasdelen B. Detection of memory impairment in a community-based system: a collaborative study. Health Soc Work. 2013 May;38(2):89-96.
  65. Özge A. Critical Evaluation of Headache Classifications. Noro Psychiatr Ars. 2013 Aug;50(Suppl 1):S8-S13. DOI: 10.4274/npa.y7279. Epub 2013 Aug 1.
  66. Ozge A. Chronic daily headache in the elderly. Curr Pain Headache Rep. 2013 Dec;17(12):382.
  67. Yurtsever S, Özge A, Kara A, Yandım A, Kalav S, Yeşil P. The relationship between care burden and social support in Turkish Alzheimer patients family caregivers: A cross-sectional study. Journal of Nursing Education and Practice, 2013, Vol. 3, No. 9
  68. Edgünlü TG, Ozge A, Yalın OÖ, Kul S, Erdal ME. A Study of the Impact of Death Receptor 4 (DR4) Gene Polymorphisms in Alzheimer’s Disease. Balkan Med J. 2013 Sep;30(3):268-72.
  69. Gül HL, Karadaş Ö, Fırtına S, Meteoğlu A, Erdemoğlu AK, Özge A, İnan LE. Sinus headache’s relationship with primary headaches; clinical and radiological evaluation. Journal of Neurological Sciences 2013. DOI: 10.1016/j.jns.2013.07.1732
  70. Bes A, et al (Ozge A, 87 co-authors) The International Classification of Headache Disorders, 3rd edition (beta version)Cephalalgia 2013;33(9):629-808. DOI: 10.1177/0333102413485658
  71. Karakurum Göksel B, Coşkun Ö, Ucler S, Karatas M, Ozge A, Ozkan S. Use of complementary and alternative medicine by a sample of Turkish primary headache patients. Agri. 2014;26(1):1-7.
  72. Uluduz D, Tavsanli ME, Uygunoğlu U, Saip S, Kasapcopur O, Ozge A, Temel GO. Primary headaches in paediatric patients with chronic rheumatic disease. Brain Dev. 2014 Nov;36(10):884-91.
  73. Antonaci F, Voiticovschi-Iosob C, Di Stefano AL, Galli F, Ozge A, Balottin U. The evolution of headache from childhood to adulthood: a review of the literature.J Headache Pain. 2014 Mar 18;15:15.
  74. Özge A, Öksüz N, Ayta S, Uluduz D, Yıldırım V, Toros F, Taşdelen B. Atopic disorders are more common in childhood migraine and correlated headache phenotype. Pediatr Int. 2014 Dec;56(6):868-872.
  75. Ozge A, Bolay H. Intracranial hypotension and hypertension in children and adolescents. Curr Pain Headache Rep. 2014 Jul;18(7):430.
  76. Günay EC, Yalin OÖ, Özge A, Erdoğan A, Kıral K, Sungur MA, Tellioğlu B, Kara PÖ, Kanık A. Are Brain SPECT Data and Neuropsychological Disturbances Correlated in Patients With Alzheimer’s Disease and Vascular Dementia? Journal of Neurological Sciences [Turkish] 31:(1)# 39; 047-059, 2014
  77. Temel GO, Ankarali H, Taşdelen B, Erdoğan S, Özge A. Comparison of Boosting Tree and Gradient Treeboost Methods for Carpal Tunnel Syndrome. Turkiye Klinikleri Journal of Biostatistics . 2014, Vol. 6 Issue 2, p67-73. 7p.
  78. Edgnülü TG, Özge A, Erdal N, Kuru O, Erdal ME. Association analysis of the functional MAOA gene promoter and MAOB gene intron 13 polymorphisms in tension type headache patients. Adv Clin Exp Med. 2014 Nov-Dec;23(6):901-6.
  79. Bıçakçı Ş, Saydağlu G, Özge A, Turkish Headache Database Working Group. Comorbidities of Migraine Results of Turkish Headache Database Working Group. Journal of Neurological Sciences 2014;31(1):80-89
  80. Özge A, Uluduz D, Selekler M, Öztürk M, Baykan B, Çınar N, Domaç FM, Zarifoğlu M, Inan LE, Akyol A, Bolay H, Uzuner GT, Erdemoğlu AK, Oksuz N, Temel GO. Gender differences in older adults with chronic migraine in Turkey. Geriatr Gerontol Int. 2015 May;15(5):652-8.
  81. Ozge A, Aydinlar E, Tasdelen B. Grey zones in the diagnosis of adult migraine without aura based on the International Classification of Headache Disorders-III beta: exploring the covariates of possible migraine without aura. Pain Res Manag. 2015 Jan-Feb;20(1):e1-7.
  82. Bolay H, Ozge A, Saginc P, Orekici G, Uludüz D, Yalın O, Siva A, Bıçakçi Ş, Karakurum B, Öztürk M. Gender influences headache characteristics with increasing age in migraine patients. Cephalalgia. 2015 Aug;35(9):792-800.
  83. Yalın OÖ, Edgünlü TG, Özge A. Different Phenotypes at Possibly Shared Genotype of Migraine Family. Austin Journal of Clinical Neurology. 2015; 2(9): 1078
  84. Akdal G, Ozge A, Ergör G. Vestibular symptoms are more frequent in migraine than in in tension type headache patients. J Neurol Sci. 2015 Oct 15;357(1-2):295-6.
  85. Özge A, Yalin OÖ. Chronic Migraine in Children and Adolescents. Curr Pain Headache Rep. 2016 Feb;20(2):14.
  86. Yalın OÖ, Uluduz D, Özge A, Sungur MA, Selekler M, Siva A. Phenotypic features of chronic migraine. J Headache Pain. 2016;17:26.
  87. Yılmaz ŞG, Erdal ME, Özge A, Sungur MA. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer’s Disease? OMICS. 2016 Aug;20(8):456-61.
  88. Ayta S, Uludüz D, Poyraz Fındık OT, Özge A. Quality of Life in Children and Adolescents With Primary Headache Disorders. Journal of Neurological Sciences [Turkish] 33:(1)# 47; 185-193, 2016
  89. Yilmaz ŞG, Erdal ME, Özge AA, Sungur MA. SNP variation in microRNA biogenesis pathway genes as a new innovation strategy for Alzheimer’s disease diagnostics: A study of 10 candidate genes in an understudied population from the Eastern Mediterranean. Alzheimer’s Disease and Associated Disorders. 30(3), pp. 203-209
  90. Karadaş Ö, Özön AÖ, Özçelik F, Özge A. Greater occipital nerve block in the treatment of triptan-overuse headache: A randomised comparative study. Acta Neurol Scand. 2017 Apr;135(4):426-433.
  91. Özge A, Uluduz D, Bolay H. Co-occurrence of migraine and atopy in children and adolescents: myth or a casual relationship? Curr Opin Neurol. 2017 Jun;30(3):287-291.
  92. Sevindik MS, Demirci S, Göksan B, Özge A, Savrun FK, Onur H, Yıldırım V, Simsek I, Ozhan H, Uludüz D. Accompanying migrainous features in paediatric migraine patients with restless legs syndrome. Neurol Sci. 2017 Sep;38(9):1677-1681.
  93. Yalin OÖ, Uludüz D, Sungur MA, Sart H, Özge A. Identification of Allodynic Migraine Patients with the Turkish Version of the Allodynia Symptom Checklist: Reliability and Consistency Study. Noro Psychiatr Ars. 2017 Sep;54(3):260-266.
  94. Özge A, Faedda N, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, Valeriani M, Sergeev A, Barlow K, Uludüz D, Yalın OÖ, Lipton RB, Rapoport A, Guidetti V. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J Headache Pain. 2017 Nov 23;18(1):109.
  95. Özge A, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, Valeriani M, Sergeev A, Barlow K, Uludüz D, Yalın OÖ, Faedda N, Lipton RB, Rapoport A, Guidetti V. Experts’ opinion about the paediatric secondary headaches diagnostic criteria of the ICHD-3 beta. J Headache Pain. 2017 Nov 29;18(1):113.
  96. Kiral K, Yetim Ü, Özge A, Aydin, A. The relationships between coping strategies, social support and depression: An investigation among Turkish care-givers of patients with dementia. Ageing and Society, 2017; 37(1), 167-187.
  97. Keight R, Aljaaf AJ, Al-Jumeily D, Hussain AJ, Ozge A, Mallucci C. An Intelligent Systems Approach to Primary Headache Diagnosis. In: Huang DS., Jo KH., Figueroa-García J. (eds) Intelligent Computing Theories and Application. ICIC 2017. Lecture Notes in Computer Science, (2017) vol 10362. Springer, Cham.
  98. Guler G, Kütük MÖ, Toros F, Özge A, Tasdelen B. The high level of psychiatric disorders associated with migraine or tension-type headache in adolescents. Journal of Neurological Sciences, 2017; 34(4). DOI: 10.24165/jns.10112.17
  99. Kutuk MO, Tufan AE, Guler G, Yalin OO, Altintas E, Bag HG, Uluduz D, Toros F, Aytan N, Kutuk O, Ozge A. Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers. Brain Dev. 2018 Nov;40(10):857-864.
  100. Yalın OÖ, Uludüz D, Özge A. Peripheral nerve blocks for the treatment of short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) during pregnancy. Agri. 2018 Jan;30(1):28-30.
  101. Ozge A, Karadas Ö. Headache Classifications. Turkiye Klinikleri J Neurol-Special Topics 2018;11(1):1-14
  102. Özön AÖ, Karadaş Ö, Özge A. Efficacy of Diet Restriction on Migraines. Noro Psychiatr Ars. 2018 Sep; 55(3): 233-237.
  103. Öksüz N, Özge A. What is the contribution of non-pharmacological procedures on the management of chronic migraine? Neurol Sci Neurophysiol 2018; 35: 60-69.
  104. Ozge A, Uluduz D, Yalin OÖ, Demirci S, Karadas Ö, Uygunoglu U. Chronic Migraine: Burden, Comorbidities, and Treatment/Chronic Migraine: Burden of Disease, Comorbidities, and Treatment. Turkish Journal of Neurology. 2018:24.2:p117+.
  105. Gültekin M, Balci E, İsmailoğulları S, Yetkin F, Baydemir R, Erdoğan F, Mirza M, Özge A. Awareness of Migraine Among Primary Care Physicians in Turkey: A Regional Study.Noro Psychiatr Ars. 2018 Dec;55(4):354-357.
  106. Derici Yıldırım D, Taşdelen B, Uludüz D, Özge A, Yoloğlu S. Impact of a new migraine-specific comorbidity index on prognosis: A methodology study. Neurol Sci Neurophysiol 2018; 35(4): 183-188.
  107. Uluduz D, Ayta S, Özge A, Yalin OÖ, Turkish Headache Database Study Group, Temel GÖ, Taşdelen B. Cranial Autonomic Features in Migraine and Migrainous Features in Cluster Headache. Noro Psychiatr Ars. 2018 Sep; 55(3): 220-224.
  108. Özge A, Karadaş Ö. Headache Classifications. Turkiye Klinikleri J Neurol-Special Topics. 2018;11(1):1-14
  109. Bes A, et al (Ozge A, 87 co-authors) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018
  110. Ertem DH, Bingol A, Ugurcan B, Mercan Ö, Simsek I, Sağlam H, Ozge A, Uluduz D.The impact of parental attitudes towards children with primary headaches. Clin Child Psychol Psychiatry. 2019 Oct;24(4):767-775.
  111. Onur OS, Ertem DH, Karsidag C, Uluduz D, Ozge A, Sıva A, Guru M. An open/pilot trial of cognitive behavioural therapy in Turkish patients with refractory chronic migraine. Cogn Neurodyn. 2019 Apr;13(2):183-189.
  112. Polat B, Özge A. “Validity and Reliability of The Turkish Version of The Mig-Scog Scale in Patients with Migraine”. Neurological Sciences and Neurophysiology 2020;37:29-35.
  113. Valeriani M, Abu-Arafeh I, Ozge A. Clinical and Pathophysiological Peculiarities of Headache in Children and Adolescents Journal: Frontiers in Neurology, section Headache Medicine and Facial Pain. Front Neurol. 2019 Dec 6;10:1280. DOI: 10.3389/fneur.2019.01280. PMID: 31866933; PMCID: PMC6908502.
  114. Uygun, Ö., Ertaş, M., Ekizoğlu, E., Bolay, H., Özge, A., Kocasoy Orhan, E., … & Baykan, B. (2020). Headache characteristics in COVID-19 pandemic-a survey study. The journal of headache and pain, 21(1), 1-10.
  115. Ashina, M., Katsarava, Z., Do, T. P., Buse, D. C., Pozo-Rosich, P., Ozge, A., … & Lipton, R. B. (2021). Migraine: epidemiology and systems of care. The Lancet, 397(10283), 1485-1495.
  116. Eigenbrodt, A. K., Ashina, H., Khan, S., Diener, H. C., Mitsikostas, D. D., Sinclair, A. J., Anna K. Eigenbrodt, Håkan Ashina, Sabrina Khan, Hans-Christoph Diener, Dimos D. Mitsikostas, Alexandra J. Sinclair, Patricia Pozo-Rosich, Paolo Martelletti, Anne Ducros, Michel Lantéri-Minet, Mark Braschinsky, Margarita Sanchez del Rio, Oved Daniel, Aynur Özge, Ayten Mammadbayli, Mihails Arons, Kirill Skorobogatykh, Vladimir Romanenko, Gisela M. Terwindt, Koen Paemeleire, Simona Sacco, Uwe Reuter, Christian Lampl, Henrik W. Schytz, Zaza Katsarava, Timothy J. Steiner & Messoud Ashina (2021). Diagnosis and management of migraine in ten steps. Nature Reviews Neurology, 17(8), 501-514.
  117. Karadaş, Ö., Öztürk, B., Sonkaya, A. R., Taşdelen, B., Özge, A., & Bolay, H. (2021). Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6. Neurological Sciences, 42(5), 1665-1673.
  118. Bolay, H., Özge, A., Uludüz, D., & Baykan, B. (2020). Are migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities?. Headache: The Journal of Head and Face Pain, 60(10), 2508-2521.
  119. Akdal, G., Ozcelik, P., & Ozge, A. (2020). Vestibular migraine: Considered from both the vestibular and the migraine point of view. Neurological Sciences and Neurophysiology, 37(2), 41.
  120. Bolay, H., Karadas, Ö., Oztürk, B., Sonkaya, R., Tasdelen, B., Bulut, T. D., Özlem Gülbahar, Aynur Özge & Baykan, B. (2021). HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. The Journal of Headache and Pain, 22(1), 1-12.
  121. Aksu, G. G., Kütük, M. Ö., Tufan, A. E., Toros, F., Uludüz, D., & Özge, A. (2020). The close relation of tic disorders with childhood migraine and atopic background of both children and mothers. Neurological Sciences and Neurophysiology, 37(3), 141.
  122. Erdal, M. E., Yilmaz, S. G., Ay, M. E., Kara, H. G., Özge, A. A., & Tasdelen, B. (2020). A study investigating the role of 2 candidate SNPs in Bax and Bcl-2 genes in Alzheimer’s disease. Puerto Rico Health Sciences Journal, 39(3), 264-269.
  123. Dikmen, P. Y., Bozdağ, M., Güneş, M., Koşak, S., Taşdelen, B., Uluduz, D., & Ozge, A. (2021). Reliability and validity of Turkish version of Headache Impact Test (HIT-6) in patients with migraine. Archives of Neuropsychiatry, 58(4), 300.
  124. Ozge, A., Genc, H., Aksu, G. G., & Uludüz, D. (2021). Migraine and frontostriatal circuit disorders: What have we learnt until now?. Neurological Sciences and Neurophysiology, 38(2), 81.
  125. Uzuner, G. T., Yalın, O. O., Uluduz, D., Ozge, A., & Uzuner, N. (2021). Migraine and cardiovascular risk factors: A clinic-based study. Clinical Neurology and Neurosurgery, 200, 106375.
  126. Yildirim, D. D., Kiraz, M. B., Tasdelen, B., & Ozge, A. (2021). Investigation of the complex structure between the severity of alzheimer’s disease and influencing factors using latent class cluster analysis. Neurological Sciences and Neurophysiology, 38(2), 120.
  127. Özge, A., Uludüz, D., Karadaş, Ö., & Mehtar Bozkurt, M. (2021). Erenumab in Mechanism-based Migraine Treatment. Turkish Journal of Neurology/Turkish Journal of Neurology, 17(3).
  128. Baykan, B., Aynur, Ö. Z. G. E., Ertaş, M., Atalar, A. C., & Bolay, H. (2021). Urgent need for ICHD criteria for COVID-19-related headache: scrutinised classification opens the way for research. Archives of Neuropsychiatry, 58(1), 79.
  129. Cengiz, Ö. K., Tavlı, E., Erhan, H., Gülgeç, B., Çolak, E., Yıldırım, D. D., & Özge, A. Experiences in a Palliative Care Unit for Dementia Patients. DOI: 10.4274/ejgg.galenos.2021.2021-6-5 Eur J Geriatr Gerontol
  130. Ozge, A., Yalin, O. O., Uluduz, D., Mercan, O., Sungur, M. A., & Siva, A. (2018, September). The relevance of associated symptoms of migraine according to migraine subtypes: A Clinical study. In JOURNAL OF HEADACHE AND PAIN (Vol. 19). CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND: SPRINGEROPEN.
  131. Atalar, A. Ç., Türk, B. G., Ekizoglu, E., Kurt Gök, D., Baykan, B., Özge, A., … & Ünlüsoy Acar, Z. (2022). Headache in idiopathic/genetic epilepsy: Cluster analysis in a large cohort. Epilepsia, 63(6), 1516-1529.
  132. Dikmen, PY, Ari C, Sahin E, Ertas M, Domac FM, Aydinlar EI, Ozge A, … & Baykan, B. (2021). Clinical Characteristics and Burden of a Large Series with Cluster Headache From Turkey: A Cross-Sectional Study From Headache Centres.
  133. Burden and Attitude to Resistant and Refractory Migraine A Survey From the European Headache Federation With the Endorsement of the European Migraine … S Sacco, C Lampl, AM Van Den Brink, V Caponnetto… – 2021 – researchsquare.com

… Devrimsel H. Ertem, Sinan Gönüllü, Elif Ilgaz Aydinlar, Levent Ertuğrul Inan, Berkay Ölmez, Taner Ozbenli, Aynur Özge, Derya Uluduz, Tugba Uyar Cankay, Pınar Yalinay Dikmen.

  1. Dikmen, Pinar Yalinay, Aynur Ozge, and Paolo Martelletti. “The use of clinical scales and PROMs in headache disorders and migraine, summarising their dissemination and operationalisation.” Heliyon (2023).
  2. Kayar, Ozan, et al. “The mediating role of early maladaptive schemas on the relationship between illness perception and pain coping strategies among adolescents diagnosed with migraine.” Frontiers in Neurology 14 (2023): 1128965.
  3. Atalar, A. Ç., Özge, A., Türk, B. G., Ekizoğlu, E., Kurt Gök, D., Baykan, B., … & IDEM Study Group. (2023). Diagnosis of comorbid migraine without aura in patients with idiopathic/genetic epilepsy based on the grey zone approach to the International Classification of Headache Disorders 3 criteria. Frontiers in Neurology, 13, 1103541.
  4. Güler Aksu, G., Kayar, O., Tufan, A. E., Kütük, M. Ö., Özdağ Acarli, A. N., Sucu, D. H., … & Özge, A. (2023). Early maladaptive schemas in episodic and chronic migraine in adolescents. Frontiers in Neurology, 14, 1128953.
  5. Ekizoglu, E., Baykan, B., Atalar, A. Ç., Türk, B. G., Gök, D. K., Topaloglu, P., Ozge A, … & IDEM Study Group. (2023). Peri-ictal headache: An underestimated prognostic finding associated with idiopathic epilepsies. Epilepsy & Behaviour, 141, 109136.
  6. Domaç, F. M., Uludüz, D., & Özge, A. (2022). Sleep Patterns Changes Depending on Headache Subtype and Covariates of Primary Headache Disorders. In Neurophysiology-Networks, Plasticity, Pathophysiology, and Behaviour. IntechOpen.
  7. Bakır, M., Rumeli, Ş., Özge, A., & Türkyılmaz, G. G. (2022). The effect of postdural puncture headache on pre-existing and new-onset headaches after cesarean section: A retrospective study. Heliyon, 8(10).
  8. Ozcelik, E. U., Uludüz, E., Karacı, R., Domaç, F. M., İskender, M., Özge, A., & Uludüz, D. (2023). Do comorbidities and triggers expedite chronicity in migraine?. Neurological Sciences and Neurophysiology, 40(1), 48.
  9. Unal-Cevik, I., Uluduz, D., & Ozge, A. (2022). A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients. Cephalalgia, 42(10), 1091-1092.
  10. Aksu, G. G., Kayar, O., Tufan, A. E., Kütük, M. Ö., Sucu, D. H., Taşdelen, B., … & Özge, A. (2022). Early maladaptive schemas differing according to sex may contribute to migraine among the youth. Brain and Development, 44(7), 427-437.
  11. Hamit, G., Ayca, O. A., Omer, B. I., Nevra, O., & Aynur, O. (2022). Association of circadian locomotor output cycles kaput rs1801260 and hypocretin receptor 1 rs2271933 polymorphisms in patients with chronic migraine and sleep disorder. Neurological Sciences and Neurophysiology, 39(2), 98.
  12. Oksuz, Nevra, and Aynur Özge. “Gray zones in the trigeminal autonomic cephalalgias.” Neurological Sciences and Neurophysiology 40.1 (2023): 15.
  13. Bülbül, N. G., Çınar, N., Özge, A., Saka, E., Oktar, A. Ç., Er, D., … & Şahiner, T. A. (2023). Evaluation of cognitive performance and daily life activities in dementia patients with online cognitive tracking and exercise application. Alzheimer’s & Dementia, 19, e064934.
  14. Özge, A., Valleriani, M., Uluduz, D., & Guidetti, V. Cognitive Schemas in Primary Headache Disorders. Frontiers in Neurology, 14, 1240559.
  15. Cengiz, Ö. K., Tavlı, E., Erhan, H., Gülgeç, B., Çolak, E., Yıldırım, D. D., & Özge, A. (2022). Experiences in a Palliative Care Unit for Patients with Dementia. European Journal of Geriatrics & Gerontology, 4(1).
  16. Genc, H., Baykan, B., Bolay, H., Uluduz, D., Unal-Cevik, I., Kissani, N., … & Ozge, A. (2023). Cross-sectional, hospital-based analysis of headache types using ICHD-3 criteria in the Middle East, Asia, and Africa: the Head-MENAA study. The journal of headache and pain, 24(1), 24.
  17. Tamborska AA, Wood GK, Westenberg E, Garcia-Azorin D, Webb G, Schiess N, Netravathi M, Baykan B, Dervaj R, Helbok R, Lant S, Ozge A, Padovani A, Saylor D, Schmutzhard E, Easton A, Lilleker JB, Jackson T, Beghi E, Ellul MA, Frontera JA, Pollak T, Nicholson TR, Wood N, Thakur KT, Solomon T, Stark RJ, Winkler AS, Michael BD; Global NeuroResearch Coalition. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study. J Neurol Sci. 2023 Jun 15;449:120646. DOI: 10.1016/j.jns.2023.120646. Epub 2023 Apr 11. Erratum in: J Neurol Sci. 2023 Aug 15;451:120709. PMID: 37100018; PMCID: PMC10085971.
  18. Kilinc, Y. B., Kilinc, E., Danis, A., Hanci, F., Turay, S., Ozge, A., & Bolay, H. (2023). Mitochondrial metabolism related markers GDF-15, FGF-21, and HIF-1α are elevated in paediatric migraine attacks. Headache: The Journal of Head and Face Pain, 63(8), 1076-1086.
  19. Onan, D., Ekizoglu, E., Arikan, H., Tasdelen, B., Ozge, A., & Martelletti, P. (2023). The efficacy of physical therapy and rehabilitation approaches in chronic migraine: a systematic review and meta-analysis. Journal of Integrative Neuroscience, 22(5).
  20. Özge A, Ghouri R, Öksüz N, Taşdelen B. (2023, Aug.) Predictive factors for Alzheimer’s disease progression: a comprehensive retrospective analysis of 3,553 cases with 211 months follow-up. Front Neurol. 2023 Aug 24;14:1239995. DOI: 10.3389/fneur.2023.1239995. PMID: 37693748; PMCID: PMC10484751.
  21. Özge, A., Domaç, F. M., Tekin, N., Sünbül, E. A., Öksüz, N., Atalar, A. Ç., … & Ungan, M. (2023). One Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases. Journal of Clinical Medicine, 12(17), 5754.
  22. Atalar, A. Ç., Acarlı, A. N. Ö., Baykan, B., Martelletti, P., Bolay, H., Ertaş, M., … & Özge, A. (2023). COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicentre follow-up study (COVA-Head Study). The Journal of Headache and Pain, 24(1), 132.
  23. Atalar, A. Ç., Özdağ Acarlı, A. N., Baykan, B., Bolay, H., Ertaş, M., Ekizoğlu, E. … Özge, A. (2023). Long-term course of COVID-19 vaccination-related headache: A prospective multicenter follow-up study. Cephalalgia, 43(8), 03331024231194024.
  24. Yılmaz, G. G., Öksüz, N., Özdemir, A. A., Ghouri, R., Özge, A. (2023). Clinical Differentiation of Chronic Migraine with and without Medication Overuse: Insights from a Retrospective Study. Cephalalgia, 43(8), 03331024231194024.
  25. Yılmaz, G. G., Öksüz, N., Özdemir, A. A., Ghouri, R., Özge, A. (2023). Factors Contributing to Changes in Chronic Migraine Patients with Fibromyalgia: A Comparative Analysis. Cephalalgia, 43(8), 03331024231194024.
  26. Uludüz, E., Uludüz, D., Özge, A., Domaç, F. M., (2023). Migraine and sleep quality. Cephalalgia, 43(8), 03331024231194024.
  27. Orhan, E. K., Kamacı, İ., Selekler, M., … Özge, A. (2023). Revolutionizing Headache Treatment: The Impact of Tele-Education on Collaborative Care Between Neurology and Algology Specialists. Cephalalgia, 43(8), 03331024231194024.
  28. Genç, H., Bolay, H., Baykan, B., … Özge, A. (2023). Headache profiles of patients who were referred to neurology clinics: A subgroup analysis of the Head-MENAA study. Cephalalgia, 43(8), 03331024231194024.
  29. Özge, A., Tekin, N., Çetingök, S. et all. (2023). Impact of Chronic Pain on Work Performance and Well-being Among Individuals in Nursing Homes: Initial Insights from Turkey’s First Established Facility. Cephalalgia, 43(8), 03331024231194024.
  30. Özge, A., Tekin, N., Çetingök, S. et all. (2023). Identifying Chronic Pain among Residents of Darulaceze Nursing Home: Preliminary Findings from Turkey’s First Established Institution. Cephalalgia, 43(8), 03331024231194024.
  31. Evlice, A., Genç, H., Uluduz, D., Baykan, B., Bolay, H., Unal-Cevik, I., … & Head-MENAA study group. (2023). Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: A cross-sectional, multicenter study. Cephalalgia, 43(8), 03331024231194024.
  32. Polat, B., Kale, A. K., Eyüpoğlu, S., Özdemir Gültekin, T., Cafer, V., Can, A. İ., Özge, A. … Uludüz, D. (2023). Vascular comorbidity and cognition in migraine. Cephalalgia, 43(8), 03331024231194024.
  33. Tepe, N., Bolay, H., Akgör, M. C. …. Özge, A. (2023). Understanding Pain Patterns in Medication Overuse Headache: Insights from Turkey’s Real Life Experience. Cephalalgia, 43(8), 03331024231194024.
  34. Dikmen, P. Y., Baykan, B., Uludüz, D., Özge, A. … Ertas, M. (2023). Real-life Experiences with Galcanezumab disclosed New Predictors for Response. Cephalalgia, 43(8), 03331024231194024.
  35. Atalar, A. Ç., Genç, H., Özçelik, E. U., Bolay, H., Uludüz, D. … Özge, A. (2023). Other primary headache disorders: data from the head-MENA-A study in the Africa, Asia and, Middle East. Cephalalgia, 43(8), 03331024231194024.
  36. Demirel, E. A., Ergin, N., Öksüz, N., Özge, A., … Uludüz, D. (2023). Distinguishing Between Migraine and Cervicogenic Headache: Key Factors for Differential Diagnosis. Cephalalgia, 43(8), 03331024231194024.
  37. Saghir, K., Mansoury, O., Şahbaz, F. G., Özçelik, E. U., Taşdelen, S., Özge, A. …Kissani, N. (2023). Fasting headache during the month of Ramadan. Cephalalgia, 43(8), 03331024231194024.
  38. Karacı, R., Sünbül, E. A., Dikmen, P. Y., Aydınlar, E. I., Bilgiç, F. … Özge, A., Domaç, S. F. Reliability and Validity of Turkish Version of Migraine Interictal Burden Scale-4 (MIBS-4) in Patients with Migraine. Cephalalgia, 43(8), 03331024231194024.
  39. Öksüz, N., & Özge, A. (2023, September) Factors Contributing to Changes in Chronic Migraine Patients with Bruxism: A Comparative Analysis. COMPREHENSIVE MEDICINE, 15(4), 356-360.
  40. Frontera, J. A., Guekht, A., Allegri, R. F., Ashraf, M., Baykan, B., Crivelli, L., … & Winkler, A. S. (2023). Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition. Journal of the Neurological Sciences, 120827.
  41. Ghouri, R., Öksüz, N., Taşdelen, B., & Özge, A. (2023). Factors affecting progression of non-Alzheimer dementia: A retrospective analysis with long-term follow-up. Frontiers in Neurology, 14.
  42. Yalinay Dikmen, P., Baykan, B., Uludüz, D., Özge, A., Ilgaz Aydınlar, E., Polat, B., … & Ertaş, M. (2023). Real-life experiences with galcanezumab and predictors for treatment response in Turkey. BMC neurology, 23(1), 418.
  43. Karakılıc, S., Oksuz, N., Ghouri, R., Ozdemir, A. A., & Ozge, A. (2023). Alzheimer’s disease and Parkinson’s disease dementia: Practical tips for physicians. Brain & Heart, 1712.
  44. Giussani, G., Westenberg, E., Garcia-Azorin, D., Bianchi, E., AHK, Y. K., Allegri, R. F., … & Winkler, A. S. (2024). Prevalence and trajectories of post-COVID-19 neurological manifestations: A systematic-review and meta-analysis. Neuroepidemiology.
  45. Özge, A., Ghouri, R., Öksüz, N., & Tasdelen, B. (2023). Early intervention and adding effective doses of EGb761 like Ginkgo extract slow down dementia progression: insights to the neurovascular unit. Frontiers in Neurology, 14, 1240655.
  46. Yilmaz, G. G., Murzakhanov, N., Yildirim, D. D., Baykan, B., Garcia-Azorin, D., Frontera, J. A., … & Özge, A. (2023). Headache Triggered by Coronavirus Disease 2019 Vaccination Increases in Line with History of Allergic Disorders and Comorbidities Like Depression and Fibromyalgia: An Analysis of the US Vaccine Adverse Event Reporting System. Neurological Sciences and Neurophysiology, 40(4), 207-214.
  47. Atalar, A. Ç., Genç, H., Özçelik, E. U., Bolay, H., Uluduz, D., Unal-Cevik, I., … & Alemayehu, B. (2024, January). Other primary headache disorders: Data from the HEAD-MENA-A study in Africa, Asia, and the Middle East. Clinical Neurology and Neurosurgery, 108112.
  48. Öksüz, N., Ghouri, R., Taşdelen, B., Uludüz, D., & Özge, A. (2024, January). Mild Cognitive Impairment Progression and Alzheimer’s Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months. Journal of Clinical Medicine, 13(2), 518.
  49. OZGE, A., GHOURI, R., ULUDÜZ, D. (2024, January). Vascular Risk Factors and Their Influence on Migraine Phenotype in Older Adults. Medical Research Archives, 12(1). DOI: 10.18103/mra.v12i1.4914
  50. Türk, B. G., Yeni, S. N., Atalar, A. Ç., Ekizoğlu, E., Gök, D. K., Baykan, B., … & Acar, Z. Ü. (2024). Exploring Shared Triggers and Potential Etiopathogenesis between Migraine and Idiopathic/Genetic Epilepsy: Insights from a Multicenter Tertiary-Based Study. Clinical Neurology and Neurosurgery, 108146. Retrievel from https://www.sciencedirect.com/science/article/abs/pii/S0303846724000337
  51. Giussani, G., Westenberg, E., Garcia-Azorin, D., Bianchi, E., AHK, Y. K., Allegri, R. F., Ozge, A., … & Winkler, A. S. (2024,January). Prevalence and trajectories of post-COVID-19 neurological manifestations: A systematic-review and meta-analysis. Neuroepidemiology. DOI: 10.1159/000536352.
  52. Özge, A. (2023, January). Are anti-CGRP therapies useful for paediatric migraine? https://www.cgrpforum.org/are-anti-cgrp-therapies-useful-for-paediatric-migraine/aynur/
  53. Yılmaz, G. G., Yılmaz, İ. A., Özge, A., & Şengül, M. T. (2024). Risk factors for white matter lesions in migraine patients: Insights for prevention and management. Neurology Asia, 29(1).
  54. Özge, A., Baykan, B., Bıçakçı, Ş., Ertaş, M., Atalar, A. Ç., Gümrü, S., & Karlı, N. (2024). Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications. Frontiers in Neurology, 15, 1402569.
  55. Göçmez Yılmaz, G., Ghouri, R., Özdemir, A. A., & Özge, A. (2024). Complicated Form of Medication Overuse Headache Is Severe Version of Chronic Migraine. Journal of Clinical Medicine, 13(13), 3696.
  56. Karaci, R., Sünbül, E. A., Dikmen, P. Y., Aydinlar, E. I., Bilgiç, F., Öksüz, N., … & Domaç, F. M. (2024). Reliability and Validity Study of the Migraine Interictal Burden Scale-4 in Turkish. Neurological Sciences and Neurophysiology, 41(3), 153-161.
  57. Akgör, M. C., Ekizoğlu, E., & Özge, A. Dairy and Headaches: What is the Connection?. Current pain and headache reports.
  58. Puledda, F., Sacco, S., Diener, H. C., Ashina, M., Al-Khazali, H. M., Ashina, S., … & Tassorelli, C. (2024). International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia, 44(8), 03331024241252666.
  59. Schwedt, T. J., Pradhan, A. A., Oshinsky, M. L., Brin, M. F., Rosen, H., Lalvani, N., … & Shapiro, R. (2024). The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group. Headache: The Journal of Head and Face Pain.
  60. Yilmaz, M., Kale, E., & Ozge, A. (2024). The link between cutaneous allodynia and pain/sensitivity in teeth and gums during migraine episodes. BMC Oral Health, 24(1), 1043.
  61. Gultekin, T. O., Eyupoglu, S., Uluduz, E., Uluduz, D., & Ozge, A. (2024). Beyond Genetics: The Role of Familial Comorbidities in Shaping Migraine Phenotypes.
  62. Peres, M. F. P., Özge, A., & Burstein, R. (2024). Headache burden among schoolchildren in Sub-Saharan Africa on the map for targeted solutions. Cephalalgia, 44(10), 03331024241288530.
  63. Öksüz N, Aksu GG, Özdemir AA, Özge A. Internalizing disorders rather than ADHD are risk factors for chronicity in pediatric migraine patients. Turk J Med Sci. 2024 Jul 12;54(5):930-937. DOI: 10.55730/1300-0144.5870. PMID: 39473734; PMCID: PMC11518378.
  64. Rosignoli, C., Ornello, R., Caponnetto, V. Ozge, A. et al. Resistant and refractory migraine – two different entities with different comorbidities? Results from the REFINE study. J Headache Pain 25, 212 (2024). DOI: 10.1186/s10194-024-01910-3
  65. Ertaş M, Saip S, Karadaş Ö, Öztürk V, Uygunoğlu U, Özge A, Üçler S, Ilgaz Aydınlar E, Yalınay Dikmen P, Uzuner N, Tekgöl Uzuner G, Bıçakçı Ş, Özbenli T, Kocasoy Orhan E, Baykan B, Ekizoğlu Turgut E, Gökçay F, Çelebisoy N, Şirin H, Bolay Belen H, Tunç T, Karlı N, Zarifoğlu M, Dora B, Inan LE, Ünal Çevik I, Neyal AM, Mehtar Bozkurt M, Siva A. A comprehensive assessment of headache characteristics, management, and burden of migraine in comparison with tension-type headache in Türkiye: Results of a cross-sectional survey of adult patients. Agri. 2025 Jan;37(1):10-23. DOI: 10.14744/agri.2024.43789. PMID: 39835955.
  66. Genç H, Özçelik EU, Barlas İÖ, Öksüz N, Özge A. Evaluation of The Impact of Hypocretin Receptor 1 rs2271933 Polymorphism on Sleep Components in Chronic Migraine Patients with Poor Sleep Quality: A Subgroup Analysis. Noro Psikiyatr Ars. 2025 Jan 17;62(1):27-33. DOI: 10.29399/npa.28553. PMID: 40046196; PMCID: PMC11877373.
  67. Dilara Onan, Halime Arıkan, Esme Ekizoğlu, Bahar Taşdelen, Aynur Özge, Paolo Martelletti. The efficacy of physiotherapy approaches in chronic tension-type headache: a systematic review and meta-analysis. Journal of Oral & Facial Pain and Headache. 2025. 39(1);34-48.
  68. Hamit Genc, Derya Uluduz, Hayrunnisa Bolay, Betul Baykan, Isin Unal-cevik, Najib Kissani, Otgonbayar Luvsannorov, Mansoureh Togha, Asena Ayca Ozdemir, Aynur Ozge, On Behalf Of The Head-menaa Study Group. Evaluating headache referral trends and practices across different settings in neurology clinics: insights from an international cross-sectional multicenter study. Journal of Oral & Facial Pain and Headache. 2025. 39(1);187-195.
  69. Valeriani M, Hershey AD, Özge A. Childhood and adolescent headache: A problem not to be ignored in the era of new therapies. Cephalalgia. 2025;45(3). DOI: 10.1177/03331024251331217
  70. Ornello R, Caponnetto V, Ahmed F, Aynur O, et al. Evidence-based guidelines for the pharmacological treatment of migraine. Cephalalgia. 2025;45(4). DOI: 10.1177/03331024241305381